Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Endotherapy for Refractory Chronic Pancreatitis

NCT04232670 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT04232670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Endotherapy for Refractory Chronic Pancreatitis
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Completed
Start date
October 9, 2020
Completion date
June 30, 2024
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic duct dilatation, pancreatic duct stone, pancreatic duct stricture